Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Paysafe announces expanded partnership with Betfred USA Sports » 09:13
09/08/21
09/08
09:13
09/08/21
09:13
PSFE

Paysafe

$8.87 /

-0.375 (-4.06%)

, PYPL

PayPal

$293.26 /

+4.23 (+1.46%)

, MA

MasterCard

$344.72 /

+4.535 (+1.33%)

, GPN

Global Payments

$158.65 /

+0.65 (+0.41%)

, PAYS

Paysign

$2.47 /

+0.01 (+0.41%)

, SQ

Square

$265.60 /

-4.14 (-1.53%)

, AAPL

Apple

$156.70 /

+2.37 (+1.54%)

, V

Visa

$226.29 /

+1.275 (+0.57%)

Paysafe (PSFE) announced…

Paysafe (PSFE) announced an expanded partnership with Betfred USA Sports, the wholly-owned U.S. subsidiary of U.K.-based bookmaker Betfred Group. Building on an existing payments relationship, the deal sees Betfred USA Sports plug into the affiliate marketing software of Income Access, Paysafe's marketing technology and services provider, for the upcoming launch of a multi-state affiliate program. The announcement marks the expansion of a partnership through which Betfred USA Sports currently leverages the Skrill USA digital wallet1 for its Iowa online sportsbook, and credit and debit card payment processing via Paysafe's best-in-breed payment gateway for its online sports-betting brand for the Colorado market. Both online gaming brands were unveiled in September 2020 and followed the launch of respective retail sportsbooks earlier that year. With its market presence and strong brand recognition, Betfred USA Sports is positioned for continued growth in the regulated U.S. iGaming space. The launch, scheduled for later this year, of its Income Access-powered affiliate program will support that objective as the operator will utilize a robust reporting and tracking platform to nurture relationships with marketing partners in both the digital and retail space. The program is set to first launch in Colorado with additional states forthcoming. The Fly notes that other publicly traded payment platforms include: PayPal Holdings (PYPL), Mastercard (MA), Global Payments (GPN), Paysign (PAYS), Square (SQ), Apple (AAPL) and Visa (V).

ShowHide Related Items >><<
V Visa
$226.29 /

+1.275 (+0.57%)

SQ Square
$265.60 /

-4.14 (-1.53%)

PYPL PayPal
$293.26 /

+4.23 (+1.46%)

PSFE Paysafe
$8.87 /

-0.375 (-4.06%)

MA MasterCard
$344.72 /

+4.535 (+1.33%)

GPN Global Payments
$158.65 /

+0.65 (+0.41%)

AAPL Apple
$156.70 /

+2.37 (+1.54%)

PSFE Paysafe
$8.87 /

-0.375 (-4.06%)

08/17/21 Compass Point
Paysafe price target lowered to $13 from $19 at Compass Point
08/12/21 BofA
Paysafe started with a Buy at BofA amid rapidly growing iGaming market
08/12/21 BofA
Paysafe initiated with a Buy at BofA
06/28/21 Cowen
Paysafe initiated with an Outperform at Cowen
PYPL PayPal
$293.26 /

+4.23 (+1.46%)

09/08/21 Citi
PayPal acquisition of Paidy 'solid strategic move,' says Citi
08/31/21 Wolfe Research
PayPal report of stock trading platform not new news, says Wolfe Research
07/29/21 KeyBanc
PayPal should be bought on any weakness, says KeyBanc
07/29/21 Morgan Stanley
Morgan Stanley bumps up PayPal price target to $340, sees 'positive indicators'
MA MasterCard
$344.72 /

+4.535 (+1.33%)

09/03/21 Deutsche Bank
Deutsche says many concerns over Visa and MasterCard are minor
08/17/21 JPMorgan
MasterCard price target raised to $430 from $427 at JPMorgan
08/12/21 Daiwa
MasterCard downgraded to Neutral from Outperform at Daiwa
08/02/21 Mizuho
MasterCard price target raised to $450 from $435 at Mizuho
GPN Global Payments
$158.65 /

+0.65 (+0.41%)

08/17/21 JPMorgan
Global Payments price target raised to $224 from $220 at JPMorgan
08/05/21 BMO Capital
Global Payments upgraded to Outperform from Market Perform at BMO Capital
08/04/21 Barclays
Global Payments price target lowered to $220 from $235 at Barclays
08/03/21 Raymond James
Global Payments price target lowered to $220 from $240 at Raymond James
PAYS Paysign
$2.47 /

+0.01 (+0.41%)

08/20/21 DA Davidson
Paysign upgraded to Buy at DA Davidson on expected accelerated growth
08/19/21 DA Davidson
Paysign upgraded to Buy from Neutral at DA Davidson
08/12/21 Ladenburg
Ladenburg upgrades Paysign to Buy, views pullback as 'attractive opportunity'
08/12/21 Ladenburg
Paysign upgraded to Buy from Neutral at Ladenburg
SQ Square
$265.60 /

-4.14 (-1.53%)

08/19/21 Truist
ValueAct's reported SOTP argument for Fiserv 'doesn't hold water,' says Truist
08/18/21 Truist
Truist starts Marqeta at Buy on next-gen vCard solutions success
08/17/21 JPMorgan
Square price target raised to $320 from $300 at JPMorgan
08/04/21 Barclays
Square price target raised to $345 from $340 at Barclays
AAPL Apple
$156.70 /

+2.37 (+1.54%)

09/08/21 Baird
Apple price target raised to $170 from $160 at Baird
09/08/21 Morgan Stanley
App Store headlines 'more bark than bite' for Apple, says Morgan Stanley
09/07/21 Barclays
Cirrus Logic upgraded to Overweight from Equal Weight at Barclays
09/01/21
Fly Intel: Top five analyst upgrades
V Visa
$226.29 /

+1.275 (+0.57%)

09/03/21 Morgan Stanley
Visa interchange risk from Amazon will pass, says Morgan Stanley
09/03/21 Credit Suisse
Visa exposure to Amazon surcharges 'small for now,' says Credit Suisse
08/17/21 JPMorgan
Visa price target raised to $267 from $249 at JPMorgan
V Visa
$226.29 /

+1.275 (+0.57%)

SQ Square
$265.60 /

-4.14 (-1.53%)

PYPL PayPal
$293.26 /

+4.23 (+1.46%)

PSFE Paysafe
$8.87 /

-0.375 (-4.06%)

PAYS Paysign
$2.47 /

+0.01 (+0.41%)

MA MasterCard
$344.72 /

+4.535 (+1.33%)

GPN Global Payments
$158.65 /

+0.65 (+0.41%)

AAPL Apple
$156.70 /

+2.37 (+1.54%)

  • 13
    Oct
V Visa
$226.29 /

+1.275 (+0.57%)

SQ Square
$265.60 /

-4.14 (-1.53%)

PYPL PayPal
$293.26 /

+4.23 (+1.46%)

MA MasterCard
$344.72 /

+4.535 (+1.33%)

AAPL Apple
$156.70 /

+2.37 (+1.54%)

V Visa
$226.29 /

+1.275 (+0.57%)

SQ Square
$265.60 /

-4.14 (-1.53%)

PYPL PayPal
$293.26 /

+4.23 (+1.46%)

PSFE Paysafe
$8.87 /

-0.375 (-4.06%)

MA MasterCard
$344.72 /

+4.535 (+1.33%)

GPN Global Payments
$158.65 /

+0.65 (+0.41%)

AAPL Apple
$156.70 /

+2.37 (+1.54%)

V Visa
$226.29 /

+1.275 (+0.57%)

SQ Square
$265.60 /

-4.14 (-1.53%)

PYPL PayPal
$293.26 /

+4.23 (+1.46%)

PSFE Paysafe
$8.87 /

-0.375 (-4.06%)

MA MasterCard
$344.72 /

+4.535 (+1.33%)

GPN Global Payments
$158.65 /

+0.65 (+0.41%)

AAPL Apple
$156.70 /

+2.37 (+1.54%)

Over a month ago
Upgrade
Paysign upgraded to Buy at DA Davidson on expected accelerated growth » 07:36
08/20/21
08/20
07:36
08/20/21
07:36
PAYS

Paysign

$2.52 /

+0.055 (+2.23%)

As previously reported,…

As previously reported, DA Davidson analyst Peter Heckmann upgraded Paysign to Buy from Neutral with an unchanged $3.50 price target. The company should see accelerating growth and expanding margins over the next six quarters as volumes in its two primary businesses have rebounded, the analyst tells investors in a research note. The decline in Plasma collection volumes will prove to be temporary, Heckmann adds, stating that the operators of collection centers should continue to raise the compensation per donation to encourage donors to return given the importance of Plasma to the medical field.

ShowHide Related Items >><<
PAYS Paysign
$2.52 /

+0.055 (+2.23%)

PAYS Paysign
$2.52 /

+0.055 (+2.23%)

08/19/21 DA Davidson
Paysign upgraded to Buy from Neutral at DA Davidson
08/12/21 Ladenburg
Ladenburg upgrades Paysign to Buy, views pullback as 'attractive opportunity'
08/12/21 Ladenburg
Paysign upgraded to Buy from Neutral at Ladenburg
05/12/21 Ladenburg
Paysign upgraded to Neutral on expected revenue recovery at Ladenburg
PAYS Paysign
$2.52 /

+0.055 (+2.23%)

Upgrade
Paysign upgraded to Buy from Neutral at DA Davidson » 06:38
08/19/21
08/19
06:38
08/19/21
06:38
PAYS

Paysign

$2.48 /

+ (+0.00%)

DA Davidson analyst Peter…

DA Davidson analyst Peter Heckmann upgraded Paysign to Buy from Neutral.

ShowHide Related Items >><<
PAYS Paysign
$2.48 /

+ (+0.00%)

PAYS Paysign
$2.48 /

+ (+0.00%)

08/12/21 Ladenburg
Ladenburg upgrades Paysign to Buy, views pullback as 'attractive opportunity'
08/12/21 Ladenburg
Paysign upgraded to Buy from Neutral at Ladenburg
05/12/21 Ladenburg
Paysign upgraded to Neutral on expected revenue recovery at Ladenburg
05/12/21 Ladenburg
Paysign upgraded to Neutral from Sell at Ladenburg
PAYS Paysign
$2.48 /

+ (+0.00%)

Upgrade
Ladenburg upgrades Paysign to Buy, views pullback as 'attractive opportunity' » 06:50
08/12/21
08/12
06:50
08/12/21
06:50
PAYS

Paysign

$2.45 /

-0.02 (-0.81%)

As previously reported,…

As previously reported, Ladenburg analyst Jon Hickman upgraded Paysign to Buy from Neutral with a price target of $3.75, up from $3.50. Q2 revenues in line with his model and up slightly year-over-year were driven by improving traffic at Plasma centers as the U.S. economy recovers from the pandemic, said Hickman, who is estimating 2021 revenue of $30.5M and modeling for a 30% increase for 2022. Given the recent decline in the share price, he sees "an attractive opportunity for growth investors," Hickman said.

ShowHide Related Items >><<
PAYS Paysign
$2.45 /

-0.02 (-0.81%)

PAYS Paysign
$2.45 /

-0.02 (-0.81%)

08/12/21 Ladenburg
Paysign upgraded to Buy from Neutral at Ladenburg
05/12/21 Ladenburg
Paysign upgraded to Neutral on expected revenue recovery at Ladenburg
05/12/21 Ladenburg
Paysign upgraded to Neutral from Sell at Ladenburg
12/23/20 Canaccord
Canaccord downgrades Paysign on lower visibility, increased risk
PAYS Paysign
$2.45 /

-0.02 (-0.81%)

Upgrade
Paysign upgraded to Buy from Neutral at Ladenburg » 06:46
08/12/21
08/12
06:46
08/12/21
06:46
PAYS

Paysign

$2.45 /

-0.02 (-0.81%)

Ladenburg analyst Jon…

Ladenburg analyst Jon Hickman upgraded Paysign to Buy from Neutral with a $3.75 price target.

ShowHide Related Items >><<
PAYS Paysign
$2.45 /

-0.02 (-0.81%)

PAYS Paysign
$2.45 /

-0.02 (-0.81%)

05/12/21 Ladenburg
Paysign upgraded to Neutral on expected revenue recovery at Ladenburg
05/12/21 Ladenburg
Paysign upgraded to Neutral from Sell at Ladenburg
12/23/20 Canaccord
Canaccord downgrades Paysign on lower visibility, increased risk
12/23/20 Canaccord
Paysign downgraded to Hold from Buy at Canaccord
PAYS Paysign
$2.45 /

-0.02 (-0.81%)

Earnings
Paysign backs FY21 revenue view $29M-$32M, consensus $30.57M » 16:13
08/10/21
08/10
16:13
08/10/21
16:13
PAYS

Paysign

$2.47 /

-0.055 (-2.18%)

Jeff Baker, Paysign CFO,…

Jeff Baker, Paysign CFO, said: "While the second quarter continued to be impacted by COVID-19 and government stimulus measures as expected, we did see improving trends as we moved through the quarter. Preliminary indications are that the improving trends will continue as long as the U.S. does not enter widespread lockdown conditions and the government does not provide additional stimulus checks to individuals. More importantly, we continue to believe that our business will benefit in the fourth quarter as unemployment subsidies for the entire country are scheduled to end in early September. For the full year 2021, we continue to forecast total revenue to be in the range of $29.0 million to $32.0 million, reflecting growth of 20% to 32%. We are raising our adjusted EBITDA forecast to be in the range of $0.75 million to $1.90 million due to the better-than-expected results this quarter and higher gross profit margin expectations given operating leverage in our model as plasma volumes recover and we add more pharma programs. We are raising our gross profit margin forecast by 150 basis points to 46.5%, which is an increase of 790 basis points over 2020. Operating expenses are expected to increase modestly between $18.0 million to $18.5 million, or 2.0% to 4.9%."

ShowHide Related Items >><<
PAYS Paysign
$2.47 /

-0.055 (-2.18%)

PAYS Paysign
$2.47 /

-0.055 (-2.18%)

05/12/21 Ladenburg
Paysign upgraded to Neutral on expected revenue recovery at Ladenburg
05/12/21 Ladenburg
Paysign upgraded to Neutral from Sell at Ladenburg
12/23/20 Canaccord
Canaccord downgrades Paysign on lower visibility, increased risk
12/23/20 Canaccord
Paysign downgraded to Hold from Buy at Canaccord
PAYS Paysign
$2.47 /

-0.055 (-2.18%)

Earnings
Paysign reports Q2 EPS (2c), consensus (1c) » 16:12
08/10/21
08/10
16:12
08/10/21
16:12
PAYS

Paysign

$2.48 /

-0.045 (-1.78%)

Reports Q2 revenue…

Reports Q2 revenue $6.65M, consensus $6.82M. "We are pleased to report a sequential improvement in our revenues and operating results for the quarter. Throughout the quarter we saw month-over-month improvements in our financial results as pandemic-related stimulus began to phase out, thus providing an incentive for individuals to supplement their income by donating plasma. This trend has continued in July despite the recent U.S. Customs and Border Protection decision affecting Mexican citizens' ability to receive compensation for donating plasma, which only impacted revenue on about 7% of our plasma centers. We continue to focus on diversifying our business and investing for sustained long-term growth. With the renewal of a major pharmaceutical hub customer and their copay programs and the addition of five new pharmaceutical copay programs that are expected to launch between now and the end of 2021, we are excited to continue to advance our capabilities and value in the patient affordability space," said Mark Newcomer, Paysign CEO.

ShowHide Related Items >><<
PAYS Paysign
$2.48 /

-0.045 (-1.78%)

PAYS Paysign
$2.48 /

-0.045 (-1.78%)

05/12/21 Ladenburg
Paysign upgraded to Neutral on expected revenue recovery at Ladenburg
05/12/21 Ladenburg
Paysign upgraded to Neutral from Sell at Ladenburg
12/23/20 Canaccord
Canaccord downgrades Paysign on lower visibility, increased risk
12/23/20 Canaccord
Paysign downgraded to Hold from Buy at Canaccord
PAYS Paysign
$2.48 /

-0.045 (-1.78%)

Over a quarter ago
Upgrade
Paysign upgraded to Neutral on expected revenue recovery at Ladenburg » 06:51
05/12/21
05/12
06:51
05/12/21
06:51
PAYS

Paysign

$3.53 /

+0.09 (+2.62%)

As previously reported,…

As previously reported, Ladenburg analyst Jon Hickman upgraded Paysign to Neutral from Sell with an unchanged price target of $3.50 after the company reported Q1 result and provided guidance for for 2021 and 2022 that points to an expected revenue recovery. Given his updated estimates for 2021 and 2022, and the recent decline in the share price, he thinks a Neutral rating is now appropriate, the analyst explained.

ShowHide Related Items >><<
PAYS Paysign
$3.53 /

+0.09 (+2.62%)

PAYS Paysign
$3.53 /

+0.09 (+2.62%)

05/12/21 Ladenburg
Paysign upgraded to Neutral from Sell at Ladenburg
12/23/20 Canaccord
Canaccord downgrades Paysign on lower visibility, increased risk
12/23/20 Canaccord
Paysign downgraded to Hold from Buy at Canaccord
11/18/20
Fly Intel: Top five analyst downgrades
PAYS Paysign
$3.53 /

+0.09 (+2.62%)

PAYS Paysign
$3.53 /

+0.09 (+2.62%)

Upgrade
Paysign upgraded to Neutral from Sell at Ladenburg » 06:41
05/12/21
05/12
06:41
05/12/21
06:41
PAYS

Paysign

$3.53 /

+0.09 (+2.62%)

Ladenburg analyst Jon…

Ladenburg analyst Jon Hickman upgraded Paysign to Neutral from Sell with a $3.50 price target.

ShowHide Related Items >><<
PAYS Paysign
$3.53 /

+0.09 (+2.62%)

PAYS Paysign
$3.53 /

+0.09 (+2.62%)

12/23/20 Canaccord
Canaccord downgrades Paysign on lower visibility, increased risk
12/23/20 Canaccord
Paysign downgraded to Hold from Buy at Canaccord
11/18/20
Fly Intel: Top five analyst downgrades
11/18/20 Canaccord
Paysign price target lowered to $9 from $11 at Canaccord
PAYS Paysign
$3.53 /

+0.09 (+2.62%)

PAYS Paysign
$3.53 /

+0.09 (+2.62%)

Earnings
PaySign sees FY21 revenue $29M-$32M, consensus $37.13M » 16:11
05/11/21
05/11
16:11
05/11/21
16:11
PAYS

Paysign

$3.53 /

+0.09 (+2.62%)

"While the first…

"While the first quarter continued to be impacted by COVID-19 and government stimulus measures, we believe those factors will begin to abate during the second half of the year and return us to growth in revenues and adjusted EBITDA both sequentially and year-over-year," said Jeff Baker, Paysign CFO. "For the full year 2021, we expect total revenue to be in the range of $29.0 million to $32.0 million, reflecting growth of 20% to 32%, and adjusted EBITDA to be in the range of $0.35 million to $1.90 million. Gross profit margins are expected to be approximately 45.0%, or an increase of 640 basis points over 2020. Operating expenses are expected to increase modestly to $18.0 million to $18.5 million, or 2.0% to 4.9%." Baker concluded, "This outlook presumes that the second-quarter results are slightly better than the first-quarter results and that we begin to see a recovery in the business in the third quarter when unemployment subsidies are scheduled to end in early September. With a non-COVID-19-impacted fourth quarter, we estimate our plasma revenue could reach $27.5 million for the full year 2021 and increase by an additional $10.0 million in 2022."

ShowHide Related Items >><<
PAYS Paysign
$3.53 /

+0.09 (+2.62%)

PAYS Paysign
$3.53 /

+0.09 (+2.62%)

12/23/20 Canaccord
Canaccord downgrades Paysign on lower visibility, increased risk
12/23/20 Canaccord
Paysign downgraded to Hold from Buy at Canaccord
11/18/20
Fly Intel: Top five analyst downgrades
11/18/20 Canaccord
Paysign price target lowered to $9 from $11 at Canaccord
PAYS Paysign
$3.53 /

+0.09 (+2.62%)

PAYS Paysign
$3.53 /

+0.09 (+2.62%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.